Suspected Pembrolizumab-Associated Encephalitis Presenting as Altered Mental Status in an Elderly Patient with Cancer: A Case Report
Immune checkpoint inhibitors such as pembrolizumab are increasingly used in cancer therapy and are associated with rare but serious immune-related neurological adverse effects, including autoimmune encephalitis.An 83-year-old woman with stage IV non-Hodgkin lymphoma presented with acute altered mental status---confusio...